Skip to main content
SpringerLink
Log in

Sexually Transmitted Diseases (STDs)

  • Chapter
  • First Online:
Andrology and Sexual Medicine

Part of the book series: Management of Urology ((MU))

  • 561 Accesses

Abstract

The term “sexually transmitted infection” (STI) refers to a pathogen that causes infection through sexual contact, whereas the term “sexually transmitted disease” (STD) refers to a recognizable disease state that has developed from an infection. Physicians and other health care providers have a crucial role in preventing and treating STIs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Towns JM, Leslie DE, Denham I, Azzato F, Fairley CK, Chen M. Painful and multiple anogenital lesions are common in men with Treponema pallidum PCR-positive primary syphilis without herpes simplex virus coinfection: a cross-sectional clinic-based study. Sex Transm Infect. 2016;92:110–5. https://doi.org/10.1136/sextrans-2015-052219.

    Article  PubMed  Google Scholar 

  2. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med. 1997;337:307–14. https://doi.org/10.1056/NEJM199707313370504.

    Article  CAS  PubMed  Google Scholar 

  3. Yang CJ, Lee NY, Chen TC, et al. One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One. 2014;9:e109667. https://doi.org/10.1371/journal.pone.0109667.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ganesan A, Mesner O, Okulicz JF, et al. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis. 2015;60:653–60. https://doi.org/10.1093/cid/ciu888.

    Article  CAS  PubMed  Google Scholar 

  5. Lukehart SA, Hook EW 3rd, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med. 1988;109:855–62. https://doi.org/10.7326/0003-4819-109-11-855.

    Article  CAS  PubMed  Google Scholar 

  6. Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005;106:1013–23. https://doi.org/10.1097/01.AOG.0000183594.45524.d2.

    Article  PubMed  Google Scholar 

  7. Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019;46:304–11. https://doi.org/10.1097/OLQ.0000000000000972.

    Article  PubMed  Google Scholar 

  8. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34:864–9. https://doi.org/10.1097/OLQ.0b013e318074e565.

    Article  PubMed  Google Scholar 

  9. Kenyon CR, Buyze J, Klebanoff M, Brotman RM. Association between bacterial vaginosis and partner concurrency: a longitudinal study. Sex Transm Infect. 2018;94:75–7. https://doi.org/10.1136/sextrans-2016-052652.

    Article  PubMed  Google Scholar 

  10. Sanchez S, Garcia PJ, Thomas KK, Catlin M, Holmes KK. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. Am J Obstet Gynecol. 2004;191:1898–906. https://doi.org/10.1016/j.ajog.2004.06.089.

    Article  CAS  PubMed  Google Scholar 

  11. Ness RB, Soper DE, Holley RL, et al. Douching and endometritis: results from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis. 2001;28:240–5. https://doi.org/10.1097/00007435-200104000-00010.

    Article  CAS  PubMed  Google Scholar 

  12. Gondwe T, Ness R, Totten PA, et al. Novel bacterial vaginosis-associated organisms mediate the relationship between vaginal douching and pelvic inflammatory disease. Sex Transm Infect. 2020;96:439–44. https://doi.org/10.1136/sextrans-2019-054191.

    Article  PubMed  Google Scholar 

  13. Abbai NS, Reddy T, Ramjee G. Prevalent bacterial vaginosis infection—a risk factor for incident sexually transmitted infections in women in Durban, South Africa. Int J STD AIDS. 2016;27:1283–8. https://doi.org/10.1177/0956462415616038.

    Article  PubMed  Google Scholar 

  14. Morris BJ, Hankins CA, Banerjee J, et al. Does male circumcision reduce women’s risk of sexually transmitted infections, cervical cancer, and associated conditions? Front Public Health. 2019;7:4. https://doi.org/10.3389/fpubh.2019.00004.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Srinivasan S, Liu C, Mitchell CM, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One. 2010;5:e10197. https://doi.org/10.1371/journal.pone.0010197.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gajer P, Brotman RM, Bai G, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4:132ra52. https://doi.org/10.1126/scitranslmed.3003605.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fethers KA, Fairley CK, Morton A, et al. Early sexual experiences and risk factors for bacterial vaginosis. J Infect Dis. 2009;200:1662–70. https://doi.org/10.1086/648092.

    Article  PubMed  Google Scholar 

  18. Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018;218:622.e1–622.e10. https://doi.org/10.1016/j.ajog.2018.02.017.

    Article  CAS  Google Scholar 

  19. Vodstrcil LA, Plummer ME, Fairley CK, et al. Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial. Sci Rep. 2019;9:3555. https://doi.org/10.1038/s41598-019-39879-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Brooks JP, Edwards DJ, Blithe DL, et al. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception. 2017;95:405–13. https://doi.org/10.1016/j.contraception.2016.11.006.

    Article  CAS  PubMed  Google Scholar 

  21. Moore KR, Harmon QE, Baird DD. Serum 25-hydroxyvitamin D and risk of self-reported bacterial vaginosis in a prospective cohort study of young African American women. J Womens Health (Larchmt). 2018;27:1278–84. https://doi.org/10.1089/jwh.2017.6804.

    Article  Google Scholar 

  22. Lokken EM, Balkus JE, Kiarie J, et al. Association of recent bacterial vaginosis with acquisition of Mycoplasma genitalium. Am J Epidemiol. 2017;186:194–201. https://doi.org/10.1093/aje/kwx043.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221:9–18.e8. https://doi.org/10.1016/j.ajog.2018.12.011.

    Article  PubMed  Google Scholar 

  24. Abbai NS, Nyirenda M, Naidoo S, Ramjee G. Prevalent herpes simplex virus-2 increases the risk of incident bacterial vaginosis in women from South Africa. AIDS Behav. 2018;22:2172–80. https://doi.org/10.1007/s10461-017-1924-1.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Brotman RM, Klebanoff MA, Nansel TR, et al. Bacterial vaginosis assessed by Gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010;202:1907–15. https://doi.org/10.1086/657320.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Laxmi U, Agrawal S, Raghunandan C, Randhawa VS, Saili A. Association of bacterial vaginosis with adverse fetomaternal outcome in women with spontaneous preterm labor: a prospective cohort study. J Matern Fetal Neonatal Med. 2012;25:64–7. https://doi.org/10.3109/14767058.2011.565390.

    Article  PubMed  Google Scholar 

  27. Cherpes TL, Wiesenfeld HC, Melan MA, et al. The associations between pelvic inflammatory disease, trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2006;33:747–52. https://doi.org/10.1097/01.olq.0000218869.52753.c7.

    Article  PubMed  Google Scholar 

  28. Nelson DB, Hanlon A, Hassan S, et al. Preterm labor and bacterial vaginosis-associated bacteria among urban women. J Perinat Med. 2009;37:130–4. https://doi.org/10.1515/JPM.2009.026.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22:1493–501. https://doi.org/10.1097/QAD.0b013e3283021a37.

    Article  PubMed  Google Scholar 

  30. Gosmann C, Anahtar MN, Handley SA, et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity. 2017;46:29–37. https://doi.org/10.1016/j.immuni.2016.12.013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. McClelland RS, Lingappa JR, Srinivasan S, et al. Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study. Lancet Infect Dis. 2018;18:554–64. https://doi.org/10.1016/S1473-3099(18)30058-6.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Cohen SE, Chew Ng RA, Katz KA, et al. Repeat syphilis among men who have sex with men in California, 2002–2006: implications for syphilis elimination efforts. Am J Public Health. 2012;102:e1–8. https://doi.org/10.2105/AJPH.2011.300383.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Johnston C, Magaret A, Srinivasan S, et al. P239 Genital HSV-2 suppression is not associated with alterations in the vaginal microbiome: a one-way, cross-over study. Sex Transm Infect. 2019;95(Suppl 1):A148.

    Google Scholar 

  34. Zozaya M, Ferris MJ, Siren JD, et al. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome. 2016;4:16. https://doi.org/10.1186/s40168-016-0161-6.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Liu CM, Hungate BA, Tobian AA, et al. Penile microbiota and female partner bacterial vaginosis in Rakai, Uganda. mBio. 2015;6:e00589. https://doi.org/10.1128/mBio.00589-15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Mehta SD. Systematic review of randomized trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women. Sex Transm Dis. 2012;39:822–30. https://doi.org/10.1097/OLQ.0b013e3182631d89.

    Article  PubMed  Google Scholar 

  37. Marrazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis. 2002;185:1307–13. https://doi.org/10.1086/339884.

    Article  PubMed  Google Scholar 

  38. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14–22. https://doi.org/10.1016/0002-9343(83)91112-9.

    Article  CAS  PubMed  Google Scholar 

  39. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol. 1991;29:297–301. https://doi.org/10.1128/JCM.29.2.297-301.1991.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Schwebke JR, Hillier SL, Sobel JD, McGregor JA, Sweet RL. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol. 1996;88:573–6. https://doi.org/10.1016/0029-7844(96)00233-5.

    Article  CAS  PubMed  Google Scholar 

  41. Coleman JS, Gaydos CA. Molecular diagnosis of bacterial vaginosis: an update. J Clin Microbiol. 2018;56:e00342–18. https://doi.org/10.1128/JCM.00342-18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Myziuk L, Romanowski B, Johnson SC. BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol. 2003;41:1925–8. https://doi.org/10.1128/JCM.41.5.1925-1928.2003.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Bradshaw CS, Morton AN, Garland SM, Horvath LB, Kuzevska I, Fairley CK. Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol. 2005;43:1304–8. https://doi.org/10.1128/JCM.43.3.1304-1308.2005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Schwebke JR, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol. 2007;196:517.e1–6. https://doi.org/10.1016/j.ajog.2007.02.048.

    Article  CAS  Google Scholar 

  45. Hillier SL, Nyirjesy P, Waldbaum AS, et al. Secnidazole treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol. 2017;130:379–86. https://doi.org/10.1097/AOG.0000000000002135.

    Article  CAS  PubMed  Google Scholar 

  46. Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Am J Obstet Gynecol. 2017;217:678.e1–9. Erratum in: Am J Obstet Gynecol 2018;219;110. https://doi.org/10.1016/j.ajog.2017.08.017.

    Article  CAS  Google Scholar 

  47. Chavoustie SE, Gersten JK, Samuel MJ, Schwebke JR. A phase 3, multicenter, prospective, open-label study to evaluate the safety of a single dose of secnidazole 2 g for the treatment of women and postmenarchal adolescent girls with bacterial vaginosis. J Womens Health (Larchmt). 2018;27:492–7. https://doi.org/10.1089/jwh.2017.6500.

    Article  Google Scholar 

  48. Livengood CH 3rd, Ferris DG, Wiesenfeld HC, et al. Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol. 2007;110:302–9. https://doi.org/10.1097/01.AOG.0000275282.60506.3d.

    Article  CAS  PubMed  Google Scholar 

  49. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole- resistant vaginal trichomoniasis. Clin Infect Dis. 2001;33:1341–6. https://doi.org/10.1086/323034.

    Article  CAS  PubMed  Google Scholar 

  50. Lewis DA, Mitjà O. Haemophilus ducreyi: from sexually transmitted infection to skin ulcer pathogen. Curr Opin Infect Dis. 2016;29:52–7. https://doi.org/10.1097/QCO.0000000000000226.

    Article  PubMed  Google Scholar 

  51. Lockett AE, Dance DA, Mabey DC, Drasar BS. Serum-free media for isolation of Haemophilus ducreyi. Lancet. 1991;338:326. https://doi.org/10.1016/0140-6736(91)90473-3.

    Article  CAS  PubMed  Google Scholar 

  52. Romero L, Huerfano C, Grillo-Ardila CF. Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults. Cochrane Database Syst Rev. 2017;12:CD012492. https://doi.org/10.1002/14651858.CD012492.pub2.

    Article  PubMed  Google Scholar 

  53. Mabey D, Peeling RW. Lymphogranuloma venereum. Sex Transm Infect. 2002;78:90–2. https://doi.org/10.1136/sti.78.2.90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. White JA. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis. 2009;22:57–66. https://doi.org/10.1097/QCO.0b013e328320a8ae.

    Article  PubMed  Google Scholar 

  55. de Vries HJ, Zingoni A, White JA, Ross JD, Kreuter A. 2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. Int J STD AIDS. 2014;25:465–74. https://doi.org/10.1177/0956462413516100.

    Article  PubMed  Google Scholar 

  56. Ward H, Martin I, Macdonald N, et al. Lymphogranuloma venereum in the United kingdom. Clin Infect Dis. 2007;44:26–32. https://doi.org/10.1086/509922.

    Article  PubMed  Google Scholar 

  57. Martin-Iguacel R, Llibre JM, Nielsen H, et al. Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur J Clin Microbiol Infect Dis. 2010;29:917–25. https://doi.org/10.1007/s10096-010-0959-2.

    Article  CAS  PubMed  Google Scholar 

  58. De Voux A, Kent JB, Macomber K, et al. Notes from the field: cluster of lymphogranuloma venereum cases among men who have sex with men—Michigan, August 2015–April 2016. MMWR Morb Mortal Wkly Rep. 2016;65:920–1. https://doi.org/10.15585/mmwr.mm6534a6.

    Article  PubMed  Google Scholar 

  59. Pallawela SN, Sullivan AK, Macdonald N, et al. Clinical predictors of rectal lymphogranuloma venereum infection: results from a multicentre case-control study in the U.K. Sex Transm Infect. 2014;90:269–74. https://doi.org/10.1136/sextrans-2013-051401.

    Article  CAS  PubMed  Google Scholar 

  60. De Vrieze NH, de Vries HJ. Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review. Expert Rev Anti Infect Ther. 2014;12:697–704. https://doi.org/10.1586/14787210.2014.901169.

    Article  CAS  PubMed  Google Scholar 

  61. Koper NE, van der Sande MA, Gotz HM, Koedijk FD, Dutch STI Clinics. Lymphogranuloma venereum among men who have sex with men in the Netherlands: regional differences in testing rates lead to underestimation of the incidence, 2006–2012. Euro Surveill. 2013;18:20561. https://doi.org/10.2807/1560-7917.ES2013.18.34.20561.

    Article  PubMed  Google Scholar 

  62. Haar K, Dudareva-Vizule S, Wisplinghoff H, et al. Lymphogranuloma venereum in men screened for pharyngeal and rectal infection, Germany. Emerg Infect Dis. 2013;19:488–92. https://doi.org/10.3201/eid1903.121028.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Riera-Monroig J, Fuertes de Vega I. Lymphogranuloma venereum presenting as an ulcer on the tongue. Sex Transm Infect. 2019;95:169–70. https://doi.org/10.1136/sextrans-2018-053787.

    Article  PubMed  Google Scholar 

  64. Andrada MT, Dhar JK, Wilde H. Oral lymphogranuloma venereum and cervical lymphadenopathy. Case report. Mil Med. 1974;139:99–101. https://doi.org/10.1093/milmed/139.2.99.

    Article  CAS  PubMed  Google Scholar 

  65. Ilyas S, Richmond D, Burns G, et al. Orolabial lymphogranuloma venereum, Michigan, USA. Emerg Infect Dis. 2019;25:2112–4. https://doi.org/10.3201/eid2511.190819.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Kersh EN, Pillay A, de Voux A, Chen C. Laboratory processes for confirmation of lymphogranuloma venereum infection during a 2015 investigation of a cluster of cases in the United States. Sex Transm Dis. 2017;44:691–4. https://doi.org/10.1097/OLQ.0000000000000667.

    Article  PubMed  PubMed Central  Google Scholar 

  67. CDC. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014. MMWR Recomm Rep. 2014;63(RR-2):1–19.

    Google Scholar 

  68. Pathela P, Jamison K, Kornblum J, Quinlan T, Halse TA, Schillinger JA. Lymphogranuloma venereum: an increasingly common anorectal infection among men who have sex with men attending New York City sexualhealthclinics. Sex Transm Dis. 2019;46:e14–7. https://doi.org/10.1097/OLQ.0000000000000921.

    Article  PubMed  Google Scholar 

  69. Cohen S, Brosnan H, Kohn R, et al. P494 Diagnosis and management of lymphogranuloma venereum (LGV) in a municipal STD clinic, San Francisco, 2016–18. Sex Transm Infect. 2019;95(Suppl 1):A229.

    Google Scholar 

  70. O’Farrell N. Donovanosis. Sex Transm Infect. 2002;78:452–7. https://doi.org/10.1136/sti.78.6.452.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Darville T, Pelvic Inflammatory Disease Workshop Proceedings Committee. Pelvic inflammatory disease: identifying research gaps—proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3–4, 2011. Sex Transm Dis. 2013;40:761–7. https://doi.org/10.1097/OLQ.0000000000000028.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Wiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amortegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis. 2005;32:400–5. https://doi.org/10.1097/01.olq.0000154508.26532.6a.

    Article  PubMed  Google Scholar 

  73. Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol. 2012;120:37–43. https://doi.org/10.1097/AOG.0b013e31825a6bc9.

    Article  PubMed  Google Scholar 

  74. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol. 2002;186:929–37. https://doi.org/10.1067/mob.2002.121625.

    Article  PubMed  Google Scholar 

  75. Wiesenfeld HC, Meyn LA, Darville T, Macio IS, Hillier SL. A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease. Clin Infect Dis. 2021;72:1181–9. https://doi.org/10.1093/cid/ciaa101.

    Article  CAS  PubMed  Google Scholar 

  76. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362–6. https://doi.org/10.1056/NEJM199605233342103.

    Article  CAS  PubMed  Google Scholar 

  77. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (Prevention of Pelvic Infection) trial. BMJ. 2010;340:c1642. https://doi.org/10.1136/bmj.c1642.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Ness RB, Hillier SL, Kip KE, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol. 2004;104:761–9. https://doi.org/10.1097/01.AOG.0000139512.37582.17.

    Article  PubMed  Google Scholar 

  79. Ness RB, Kip KE, Hillier SL, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol. 2005;162:585–90. https://doi.org/10.1093/aje/kwi243.

    Article  PubMed  Google Scholar 

  80. Haggerty CL, Totten PA, Tang G, et al. Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sex Transm Infect. 2016;92:441–6. https://doi.org/10.1136/sextrans-2015-052285.

    Article  PubMed  Google Scholar 

  81. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:17–27. https://doi.org/10.1016/j.virol.2004.03.033.

    Article  CAS  PubMed  Google Scholar 

  82. Kreisel KM, Spicknall IH, Gargano JW, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018. Sex Transm Dis. 2021;48:208–14. https://doi.org/10.1097/OLQ.0000000000001355.

    Article  PubMed  Google Scholar 

  83. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000;151:1158–71. https://doi.org/10.1093/oxfordjournals.aje.a010166.

    Article  CAS  PubMed  Google Scholar 

  84. Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41:660–4. https://doi.org/10.1097/OLQ.0000000000000193.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6:204. https://doi.org/10.1016/S1470-2045(05)70086-3.

    Article  PubMed  Google Scholar 

  86. Gotovtseva EP, Kapadia AS, Smolensky MH, Lairson DR. Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis. Sex Transm Dis. 2008;35:346–51. https://doi.org/10.1097/OLQ.0b013e31815ea8d1.

    Article  CAS  PubMed  Google Scholar 

  87. Baker DA, Ferris DG, Martens MG, et al. Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies. Infect Dis Obstet Gynecol. 2011;2011:806105. https://doi.org/10.1155/2011/806105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Mashiah J, Brenner S. Possible mechanisms in the induction of vitiligo- like hypopigmentation by topical imiquimod. Clin Exp Dermatol. 2008;33:74–6.

    CAS  PubMed  Google Scholar 

  89. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med. 1994;121:847–54. https://doi.org/10.7326/0003-4819-121-11-199412010-00004.

    Article  CAS  PubMed  Google Scholar 

  90. Engelberg R, Carrell D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis. 2003;30:174–7. https://doi.org/10.1097/00007435-200302000-00015.

    Article  PubMed  Google Scholar 

  91. Masese L, Baeten JM, Richardson BA, et al. Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012. AIDS. 2015;29:1077–85. https://doi.org/10.1097/QAD.0000000000000646.

    Article  PubMed  Google Scholar 

  92. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403–9. https://doi.org/10.1086/429411.

    Article  PubMed  Google Scholar 

  93. Pilcher CD, Eron JJ Jr, Vemazza PL, et al. Sexual transmission during the incubation period of primary HIV infection. JAMA. 2001;286:1713–4. https://doi.org/10.1001/jama.286.14.1713.

    Article  CAS  PubMed  Google Scholar 

  94. Legarth RA, Ahlström MG, Kronborg G, et al. Long-term mortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study. J Acquir Immune Defic Syndr. 2016;71:213–8. https://doi.org/10.1097/QAI.0000000000000825.

    Article  PubMed  Google Scholar 

  95. Marcus JL, Chao CR, Leyden WA, et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr. 2016;73:39–46. https://doi.org/10.1097/QAI.0000000000001014.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375:830–9. https://doi.org/10.1056/NEJMoa1600693.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171–81. https://doi.org/10.1001/jama.2016.5148.

    Article  PubMed  Google Scholar 

  98. Bavinton BR, Pinto AN, Phanuphak N, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5:e438–47. https://doi.org/10.1016/S2352-3018(18)30132-2.

    Article  PubMed  Google Scholar 

  99. Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393:2428–38. https://doi.org/10.1016/S0140-6736(19)30418-0.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1–17.

    PubMed  Google Scholar 

  101. DiNenno EA, Prejean J, Irwin K, et al. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men—United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:830–2. https://doi.org/10.15585/mmwr.mm6631a3.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Owens DK, Davidson KW, Krist AH, et al. Screening for HIV infection: US Preventive Services Task Force recommendation statement. JAMA. 2019;321:2326–36. https://doi.org/10.1001/jama.2019.6587.

    Article  PubMed  Google Scholar 

  103. Centers for Disease Control and Prevention. Health and Human Services Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1- infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, AIDSinfo; 2014. https://npin.cdc.gov/publication/recommendations-use-antiretroviral-drugs-pregnant-hiv-1-infected-women-maternal-health.

  104. Committee on Obstetric Practice HIV Expert Work Group. ACOG Committee opinion no. 752: prenatal and perinatal human immunodeficiency virus testing. Obstet Gynecol. 2018;132:e138–42. https://doi.org/10.1097/AOG.0000000000002825.

    Article  Google Scholar 

  105. Calabrese SK, Mayer KH. Providers should discuss U=U with all patients living with HIV. Lancet HIV. 2019;6:e211–3. https://doi.org/10.1016/S2352-3018(19)30030-X.

    Article  PubMed  Google Scholar 

  106. Gilbert P, Ciccarone D, Gansky SA, et al. Interactive “Video Doctor” counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings. PLoS One. 2008;3:e1988. https://doi.org/10.1371/journal.pone.0001988.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Alter HJ, Purcell RH, Gerin JL, et al. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun. 1977;16:928–33. https://doi.org/10.1128/IAI.16.3.928-933.1977.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Villarejos VM, Visoná KA, Gutiérrez A, Rodríguez A. Role of saliva, urine and feces in the transmission of type B hepatitis. N Engl J Med. 1974;291:1375–8. https://doi.org/10.1056/NEJM197412262912602.

    Article  CAS  PubMed  Google Scholar 

  109. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99. https://doi.org/10.1002/hep.29800.

    Article  PubMed  Google Scholar 

  110. Lockart I, Matthews GV, Danta M. Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM. Curr Opin Infect Dis. 2019;32:31–7. https://doi.org/10.1097/QCO.0000000000000515.

    Article  PubMed  Google Scholar 

  111. Terrault NA, Dodge JL, Murphy EL, et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013;57:881–9. https://doi.org/10.1002/hep.26164.

    Article  PubMed  Google Scholar 

  112. Price JC, McKinney JE, Crouch PC, et al. Sexually acquired hepatitis C infection in HIV-uninfected men who have sex with men using preexposure prophylaxis against HIV. J Infect Dis. 2019;219:1373–6. https://doi.org/10.1093/infdis/jiy670.

    Article  CAS  PubMed  Google Scholar 

  113. Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis. 2012;54:1167–78. https://doi.org/10.1093/cid/cir991.

    Article  PubMed  Google Scholar 

  114. Brettler DB, Mannucci PM, Gringeri A, et al. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood. 1992;80:540–3. https://doi.org/10.1182/blood.V80.2.540.540.

    Article  CAS  PubMed  Google Scholar 

  115. Kao JH, Hwang YT, Chen PJ, et al. Transmission of hepatitis C virus between spouses: the important role of exposure duration. Am J Gastroenterol. 1996;91:2087–90.

    CAS  PubMed  Google Scholar 

  116. Loo SK, Tang WY, Lo KK. Clinical significance of Trichomonas vaginalis detected in Papanicolaou smear: a survey in female Social Hygiene Clinic. Hong Kong Med J. 2009;15:90–3.

    PubMed  Google Scholar 

  117. Howe K, Kissinger PJ. Single-dose compared with multidose metronidazole for the treatment of trichomoniasis in women: a meta- analysis. Sex Transm Dis. 2017;44:29–34. https://doi.org/10.1097/OLQ.0000000000000537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Galiczynski EM Jr, Elston DM. What’s eating you? Pubic lice (Pthirus pubis). Cutis. 2008;81:109–14.

    PubMed  Google Scholar 

  119. Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol. 2002;138:220–4. https://doi.org/10.1001/archderm.138.2.220.

    Article  CAS  PubMed  Google Scholar 

  120. Yoon KS, Gao JR, Lee SH, Clark JM, Brown L, Taplin D. Permethrin- resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol. 2003;139:994–1000. https://doi.org/10.1001/archderm.139.8.994.

    Article  CAS  PubMed  Google Scholar 

  121. Burkhart CG, Burkhart CN. Oral ivermectin for Phthirus pubis. J Am Acad Dermatol. 2004;51:1037–8. https://doi.org/10.1016/j.jaad.2004.04.041.

    Article  PubMed  Google Scholar 

  122. Scott GR, Chosidow O, IUSTI/WHO. European guideline for the management of pediculosis pubis, 2010. Int J STD AIDS. 2011;22:304–5. https://doi.org/10.1258/ijsa.2011.011114.

    Article  CAS  PubMed  Google Scholar 

  123. Goldust M, Rezaee E, Raghifar R, Hemayat S. Comparing the efficacy of oral ivermectin vs malathion 0.5% lotion for the treatment of scabies. Skinmed. 2014;12:284–7.

    PubMed  Google Scholar 

  124. Leung AKC, Lam JM, Leong KF. Scabies: a neglected global disease. Curr Pediatr Rev. 2020;16:33–42. https://doi.org/10.2174/1573396315666190717114131.

    Article  PubMed  Google Scholar 

  125. Shimose L, Munoz-Price LS. Diagnosis, prevention, and treatment of scabies. Curr Infect Dis Rep. 2013;15:426–31. https://doi.org/10.1007/s11908-013-0354-0.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Careggi Hospital, University of Florence, Florence, Italy

    Andrea Cocci & Andrea Romano

Authors
  1. Andrea Cocci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Romano
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, Gulhane Research and Training Hospital University of Health Sciences, Ankara, Turkey

    Selcuk Sarikaya

  2. Department of Urology, University of Catania, Catania, Italy

    Giorgio Ivan Russo

  3. Department of Urology, University College London Hospitals, London, UK

    David Ralph

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cocci, A., Romano, A. (2022). Sexually Transmitted Diseases (STDs). In: Sarikaya, S., Russo, G.I., Ralph, D. (eds) Andrology and Sexual Medicine . Management of Urology. Springer, Cham. https://doi.org/10.1007/978-3-031-12049-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-12049-7_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-12048-0

  • Online ISBN: 978-3-031-12049-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation